Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

doi:10.1007/s00198-009-1107-7

中山醫學大學機構典藏 CSMUIR > 醫學院 > 醫學系 > 期刊論文 > Item 310902500/3627

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/3627

Title:	Increased serum osteopontin is a risk factor for osteoporosis in menopausal women
Authors:	I.-C. Chang;T.-I. Chiang;K.-T. Yeh;H. Lee;Y.-W. Cheng
Contributors:	中山醫學大學：醫學系
Keywords:	Bone mineral density;Estrogen;Osteopontin (OPN);Postmenopausal osteoporosis
Date:	2010
Issue Date:	2011-03-16T02:28:26Z (UTC)
ISSN:	0937-941X
Abstract:	Summary Osteopontin (OPN)-deficient mice are resistant to ovariectomy-induced osteoporosis. Therefore, we hypothesized that women with OPN overexpression may show less resistance to postmenopausal osteoporosis. In this study, we first demonstrated that serum OPN levels could be used as a biomarker for the early diagnosis of osteoporosis in postmenopausal women. Introduction Animal studies indicate that OPN-deficient mice are resistant to ovariectomy-induced osteoporosis. Methods From 2004 to 2006, 124 women over the age of 45 were enrolled in a menopausal group, while another 95 women, from 25 to 45 years of age with regular menstruation, were enrolled into a childbearing age group. The serum concentrations of OPN were calculated using the enzyme-link immunosorbent assay method, and bone mineral densities were determined with dual energy X-ray absorptiometry. Results Serum OPN levels had a significant positive correlation with age (menopausal group, p?<?0.0001) and a negative correlation with body weight, height, hip bone mineral density, and T-scores in the menopausal group. In contrast, there was a positive correlation with the E2 concentration and height, but there was no significant association with the above variables in the childbearing age group. Additionally, high serum OPN levels (>14.7 ng/ml) was a significant risk factor causing menopausal osteoporosis (odds ratio?=?2.96, 95% confidence interval, 1.055–8.345). Conclusion Serum OPN levels could be used as a biomarker for the early diagnosis of osteoporosis in postmenopausal women.
URI:	https://ir.csmu.edu.tw:8080/handle/310902500/3627 http://dx.doi.org/10.1007/s00198-009-1107-7
Relation:	Osteoporosis International,Volume 21, Number 8, 1401-1409;DOI: 10.1007/s00198-009-1107-7
Appears in Collections:	[醫學系] 期刊論文

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	251	View/Open

Loading...